Products for Research Use Only
RegisterLogin

JNJ-3738

CAT: 0804-HY-172194Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-172194Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
JNJ-3738 (Compound 148) is the inhibitor for CDK7 with a Ki of 21.75 nM. JNJ-3738 inhibits the proliferation of CDK7 WT expressing A549 with pIC50 of 7.37[1].
CAS Number
2796279-20-2
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
C[C@@H]1C2=C(N3CCS(=O)(CC3)=O)N=CN=C2NC4=CC(C5CCN(C6CN(C6)C(C#CC)=O)CC5)=CC(C)=C4O1
Molecular Formula
C29H36N6O4S
Molecular Weight
564.70
References & Citations
[1]Stansfield I, et al., Tricyclic pyrimidines as cyclin-dependent kinase 7 (cdk7) inhibitors. WO2022136174
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P991172JNJ-70218902
HY-113751-01JNJ-39393406
HY-132895JNJ-67569762
HY-118424-01JNJ-55511118
HY-110132-01JNJ-27141491
HY-19917-01JNJ-39220675
HY-123531JNJ 10329670
HY-148240-01JNJ-65355394
HY-111066-01JNJ-37822681
HY-120595-01JNJ-49095397

Alternative Products

CatalogName
MBS131356JNJ-63533054 (JNJ63533054; JNJ 63533054)
TL312033VKCNA3 Human shRNA Lentiviral Particle (Locus ID 3738)
BA6861-10JNJ-42253432
A4361-50JNJ-1661010
BA6753-5.1JNJ-61432059
BA6849-10JNJ-55308942
C4122-10JNJ-42165279
BA5559-5.1JNJ-40411813
B5553-5JNJ 10397049
B1574-10JNJ-7777120

Popular Products